Evidence map›Paper›PMID 29859014›Full record

ReviewBritish journal of clinical pharmacology2018

Medical cannabis: aligning use to evidence-based medicine approach.

Lihi Bar-Lev Schleider, Ran Abuhasira, Victor Novack

Abstract readReview
In one paragraph

Review in British journal of clinical pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Guideline
  2. State of the Science: Health Care Provider Communication of Cannabis Use Among Adults Living with Cancer.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Review
  3. Cannabinoids in Periodontology: Where Are We Now?Antibiotics (Basel, Switzerland) · 2023
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Pharmaceuticals (Basel, Switzerland) · 2021
    Article
  10. Full-SpectrumACS applied materials & interfaces · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Medical cannabis: aligning use to evidence-based medicine approach.British journal of clinical pharmacology · 2018
    Review
  15. Care and concern with cannabinoids used therapeutically.British journal of clinical pharmacology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lihi Bar-Lev SchleiderCannabis Clinical Research Institute, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel.
Ran AbuhasiraCannabis Clinical Research Institute, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel.
Victor NovackCannabis Clinical Research Institute, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel.ORCID 0000-0001-8706-9622

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the past decade we have been witnessing a rise in medical cannabis use, yet the evidence for the safety and efficacy of the various cannabinoid compounds is scarce. The State of Israel has always been at the forefront of clinical and translational research in support of Evidence Based Medicine. With respect to cannabis Israel has created a medical and regulatory environment that enables clinical studies with cannabis which may lead to improved Evidence Based use of these compounds. This opinion paper discusses selected studies into the safety and effects of cannabis derived products.

Indexed as

Evidence-Based MedicineCannabinoidsHumansIsraelMedical MarijuanaTranslational Research, BiomedicalCannabinoidsMedical Marijuana

Identifiers

PMID29859014
PMCPMC6177696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.